Search for: "BRISTOL-MYERS SQUIBB"
Results 441 - 460
of 863
Sort by Relevance
|
Sort by Date
8 Jun 2013, 6:00 pm
According to a status report provided by the makers of Plavix, Bristol-Myers Squibb and Sanofi-Aventis, there are complaints with a total of 1,036 individual claims contained in those lawsuits that have been recently transferred to the MDL court. [read post]
6 Jun 2013, 5:00 am
Bristol-Myers Squibb Co., No. 12 Civ. 2238 (JPO), slip op. [read post]
5 Jun 2013, 5:29 am
Bristol-Myers Squibb, 97 F. [read post]
19 May 2013, 9:12 am
Bristol-Myers Squibb Co., No. [read post]
12 May 2013, 9:02 pm
Bristol-Myers Squibb Co. v. [read post]
6 May 2013, 4:33 pm
Thus, reciting Bristol-Myers Squibb Co. v Ben Venue Labs. [read post]
4 May 2013, 10:13 am
Onglyza (saxagliptin) was approved by the FDA in 2009 and is manufactured by Bristol-Myers Squibb and AstraZeneca. [read post]
2 May 2013, 1:34 pm
Bristol-Myers Squibb, 246 F.3d at 1376." [read post]
30 Apr 2013, 12:14 pm
Bristol-Myers Squibb Company, 2013 U.S. [read post]
4 Apr 2013, 12:48 pm
Reports of pancreatitis associated with type 2 diabetes medications, including Merck’s Januvia and Bristol-Myers Squibb’s Byetta and Bydureon, have forced the Food and Drug Administration (FDA) to begin a safety review. [read post]
25 Mar 2013, 2:38 pm
Food and Drug Administration, it was reviewing unpublished data by medical researchers which suggest that pre-cancerous cellular changes may be associated with Type 2 diabetes drugs known as incretin mimetics, including Bristol-Myers Squibb’s Byetta and Novo Nordisk’s Victoza. [read post]
22 Mar 2013, 2:52 pm
Byetta, made by Bristol-Myers Squibb and Januvia, manufactured by Merck are two such diabetes drugs that have caused concern. [read post]
4 Mar 2013, 7:05 am
Glucagonlike peptide 1(GLP-1) therapies that include exenatide - marketed as Byetta by an alliance between Bristol-Myers Squibb and AstraZeneca - and sitagliptin - marketed as Januvia by Merck - have been linked to pancreatitis before in studies on animals and small groups of patients, said the study's lead author. [read post]
1 Mar 2013, 9:53 pm
As reported, Bristol-Myers Squibb, Roche and Boehringer-Ingelheim have plans to join the pool. [read post]
28 Feb 2013, 9:45 am
Bristol Myers Squibb. [read post]
26 Feb 2013, 9:02 am
On the agenda: • Two keynote addresses by USPTO’s Teresa Stanek Rea and WIPO’s James Pooley • AIA and NPEs: one year on • Lessons from Canadian reforms • Monetization of patents: strategies for deriving maximum value from your patent portfolio • Life sciences & ITC industries focus • Doing business in China: how to ensure your patented assets in China are making you money Speakers: • James Pooley, deputy director general for innovation and… [read post]
25 Feb 2013, 2:39 pm
Bristol Myers Squibb Co., No. 2013 U.S. [read post]
20 Feb 2013, 7:37 am
Bristol-Myers Squibb Company v. [read post]
15 Feb 2013, 9:29 am
Bristol-Myers Squibb Company v. [read post]
13 Feb 2013, 11:49 pm
For those interested, the Indian patent number is 213457 and the case details are: Bristol-Myers Squibb Company v. [read post]
